Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 215 articles:
HTML format



Single Articles


    January 2024
  1. PARKS ME
    Stochastic model of Alzheimer's disease progression using two-state Markov chains.
    PLoS One. 2024;19:e0295578.
    PubMed     Abstract available


  2. KONG F, Wu T, Dai J, Cai J, et al
    Knowledge domains and emerging trends of Genome-wide association studies in Alzheimer's disease: A bibliometric analysis and visualization study from 2002 to 2022.
    PLoS One. 2024;19:e0295008.
    PubMed     Abstract available


  3. GAMMIE SC, Messing A, Hill MA, Kelm-Nelson CA, et al
    Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
    PLoS One. 2024;19:e0291995.
    PubMed     Abstract available



  4. Editorial Note: Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease.
    PLoS One. 2024;19:e0297928.
    PubMed    


  5. NEUDORF B, Dinh C, Barnes V, Stergiou-Dayment C, et al
    Enhancing Minds in Motion(R) as a virtual program delivery model for people living with dementia and their care partners.
    PLoS One. 2024;19:e0291166.
    PubMed     Abstract available


  6. PAPAZOGLOU A, Henseler C, Weickhardt S, Teipelke J, et al
    Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice.
    PLoS One. 2024;19:e0296959.
    PubMed     Abstract available


  7. BELLIO TA, Laguna-Torres JY, Campion MS, Chou J, et al
    Perinatal choline supplementation prevents learning and memory deficits and reduces brain amyloid Abeta42 deposition in AppNL-G-F Alzheimer's disease model mice.
    PLoS One. 2024;19:e0297289.
    PubMed     Abstract available


  8. SINGH S, Cocoros NM, Li X, Mazor KM, et al
    Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controll
    PLoS One. 2024;19:e0297562.
    PubMed     Abstract available


  9. KO YK, Kim E, Lee EJ, Nam SJ, et al
    Enrichment of infection-associated bacteria in the low biomass brain bacteriota of Alzheimer's disease patients.
    PLoS One. 2024;19:e0296307.
    PubMed     Abstract available


    January 2023
  10. COUGHLAN G, Plumb W, Zhukovsky P, Aung MH, et al
    Vestibular contribution to path integration deficits in 'at-genetic-risk' for Alzheimer's disease.
    PLoS One. 2023;18:e0278239.
    PubMed     Abstract available


  11. CHANG HT, Chiu PY
    Development of a simple screening tool for determining cognitive status in Alzheimer's disease.
    PLoS One. 2023;18:e0280178.
    PubMed     Abstract available


  12. DEBNATH S, Sharma D, Chaudhari SY, Sharma R, et al
    Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
    PLoS One. 2023;18:e0279616.
    PubMed     Abstract available


  13. SHAFIGHI K, Villeneuve S, Rosa Neto P, Badhwar A, et al
    Social isolation is linked to classical risk factors of Alzheimer's disease-related dementias.
    PLoS One. 2023;18:e0280471.
    PubMed     Abstract available


  14. CHATTERJEE S, Sealey M, Ruiz E, Pegasiou CM, et al
    Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration.
    PLoS One. 2023;18:e0262792.
    PubMed     Abstract available


  15. ZHENG X, Cawood J, Hayre C, Wang S, et al
    Computer assisted diagnosis of Alzheimer's disease using statistical likelihood-ratio test.
    PLoS One. 2023;18:e0279574.
    PubMed     Abstract available


  16. JETT S, Dyke JP, Boneu Yepez C, Zarate C, et al
    Effects of sex and APOE epsilon4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.
    PLoS One. 2023;18:e0281302.
    PubMed     Abstract available


  17. LANDES SD, Finan JM, Turk MA
    Reporting Down syndrome on the death certificate for Alzheimer disease/unspecified dementia deaths.
    PLoS One. 2023;18:e0281763.
    PubMed     Abstract available


  18. SOREQ L, Bird H, Mohamed W, Hardy J, et al
    Single-cell RNA sequencing analysis of human Alzheimer's disease brain samples reveals neuronal and glial specific cells differential expression.
    PLoS One. 2023;18:e0277630.
    PubMed     Abstract available


  19. TIAN Y, Kuruvilla MV, Park M
    The use of virtual reality in screening for preclinical Alzheimer's disease: A scoping review protocol.
    PLoS One. 2023;18:e0282436.
    PubMed     Abstract available


  20. GARCIA MANRIQUEZ BA, Papapanagiotou JA, Strysick CA, Green EH, et al
    Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
    PLoS One. 2023;18:e0275137.
    PubMed     Abstract available


  21. KARAMACOSKA D, Chan DKY, Leung I, Liu JX, et al
    Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.
    PLoS One. 2023;18:e0265285.
    PubMed     Abstract available


  22. SHOBEIRI P, Alilou S, Jaberinezhad M, Zare F, et al
    Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281784.
    PubMed     Abstract available


  23. LI Y, Liu H, Li R
    Study of Bayesian variable selection method on mixed linear regression models.
    PLoS One. 2023;18:e0283100.
    PubMed     Abstract available


  24. LEE LH, Wu SC, Ho CF, Liang WL, et al
    White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    PLoS One. 2023;18:e0283790.
    PubMed     Abstract available


  25. MRAZ H, Tong CY, Liu KPY
    Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial.
    PLoS One. 2023;18:e0283449.
    PubMed     Abstract available


  26. AMORIM IS, Challal S, Cistarelli L, Dorval T, et al
    A seeding-based neuronal model of tau aggregation for use in drug discovery.
    PLoS One. 2023;18:e0283941.
    PubMed     Abstract available


  27. FAISAL M, Aid J, Nodirov B, Lee B, et al
    Preclinical trials in Alzheimer's disease: Sample size and effect size for behavioural and neuropathological outcomes in 5xFAD mice.
    PLoS One. 2023;18:e0281003.
    PubMed     Abstract available


  28. BAKER E, Leonenko G, Schmidt KM, Hill M, et al
    What does heritability of Alzheimer's disease represent?
    PLoS One. 2023;18:e0281440.
    PubMed     Abstract available


  29. GIRGIN M, Isik S, Kantarci-Carsibasi N
    Proposing novel natural compounds against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2023;18:e0284994.
    PubMed     Abstract available


  30. BAUZA M, Krstulovic M, Krupic J
    Unsupervised, frequent and remote: A novel platform for personalised digital phenotyping of long-term memory in humans.
    PLoS One. 2023;18:e0284220.
    PubMed     Abstract available


  31. ALATRANY AS, Khan W, Hussain A, Al-Jumeily D, et al
    Wide and deep learning based approaches for classification of Alzheimer's disease using genome-wide association studies.
    PLoS One. 2023;18:e0283712.
    PubMed     Abstract available


  32. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    PubMed     Abstract available


  33. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    PubMed     Abstract available


  34. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    PubMed     Abstract available


  35. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    PubMed     Abstract available


  36. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    PubMed     Abstract available


  37. JEMIMAH S, Chabib CMM, Hadjileontiadis L, AlShehhi A, et al
    Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0285346.
    PubMed     Abstract available


  38. SU Y, Wang D, Liu N, Yang J, et al
    Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced Alzheimer's disease mice via suppressing TLR4 signaling pathway through the gut-brain axis.
    PLoS One. 2023;18:e0286086.
    PubMed     Abstract available


  39. BRAUN DJ, Frazier HN, Davis VA, Coleman MJ, et al
    Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease does not significantly alter amyloid-associated neuropathology.
    PLoS One. 2023;18:e0286495.
    PubMed     Abstract available


  40. RADWAN AA, Alanazi FK, Raish M
    Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
    PLoS One. 2023;18:e0286195.
    PubMed     Abstract available


  41. JEONG WC, Min JY, Kang TG, Bae H, et al
    Association between pseudoexfoliation and Alzheimer's disease-related brain atrophy.
    PLoS One. 2023;18:e0286727.
    PubMed     Abstract available


  42. TSIANOU CC, Kvetina J, Radochova V, Kohoutova D, et al
    The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.
    PLoS One. 2023;18:e0286386.
    PubMed     Abstract available


  43. HANTKE NC, Kaye J, Mattek N, Wu CY, et al
    Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.
    PLoS One. 2023;18:e0286812.
    PubMed     Abstract available


  44. WU S, Stogios N, Hahn M, Navagnanavel J, et al
    Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286887.
    PubMed     Abstract available


  45. MUURLING M, Pasmooij AMG, Koychev I, Roik D, et al
    Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.
    PLoS One. 2023;18:e0285807.
    PubMed     Abstract available


  46. KHAYER N, Motamed N, Marashi SA, Goshadrou F, et al
    RT-DOb, a switch gene for the gene pair Csf1r, Milr1, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
    PLoS One. 2023;18:e0288134.
    PubMed     Abstract available


  47. MEKLI K, Lophatananon A, Maharani A, Nazroo JY, et al
    Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people.
    PLoS One. 2023;18:e0288045.
    PubMed     Abstract available


  48. THAMMASART S, Namchaiw P, Pasuwat K, Tonsomboon K, et al
    Attenuation Abeta1-42-induced neurotoxicity in neuronal cell by 660nm and 810nm LED light irradiation.
    PLoS One. 2023;18:e0283976.
    PubMed     Abstract available


  49. WILLIAMS E, Theys C, McAuliffe M
    Lexical-semantic properties of verbs and nouns used in conversation by people with Alzheimer's disease.
    PLoS One. 2023;18:e0288556.
    PubMed     Abstract available


  50. SUN Z, Zhang Y, Zhang M, Zhou S, et al
    Integrated brain and plasma dual-channel metabolomics to explore the treatment effects of Alpinia oxyphyllaFructus on Alzheimer's disease.
    PLoS One. 2023;18:e0285401.
    PubMed     Abstract available


  51. NI P, Pan K, Zhao B
    Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    PLoS One. 2023;18:e0289068.
    PubMed     Abstract available


  52. LU H, Li J, Yang NS, Lam LCW, et al
    Using gamma-band transcranial alternating current stimulation (tACS) to improve sleep quality and cognition in patients with mild neurocognitive disorders due to Alzheimer's disease: A study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0289591.
    PubMed     Abstract available


  53. MONIN JK, McAvay G, Zang E, Vander Wyk B, et al
    Associations between dementia staging, neuropsychiatric behavioral symptoms, and divorce or separation in late life: A case control study.
    PLoS One. 2023;18:e0289311.
    PubMed     Abstract available


  54. YOON JA, Kong IJ, Choi I, Cha J, et al
    Correlation between cerebral hemodynamic functional near-infrared spectroscopy and positron emission tomography for assessing mild cognitive impairment and Alzheimer's disease: An exploratory study.
    PLoS One. 2023;18:e0285013.
    PubMed     Abstract available


  55. BASTOS M, da Silva MP, da Silva D, Negrao GN, et al
    Factors associated with Alzheimer's disease prevalence and mortality in Brazil-An ecological study.
    PLoS One. 2023;18:e0283936.
    PubMed     Abstract available


  56. ROVANG MS, Selnes P, MacIntosh BJ, Rasmus Groote I, et al
    Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    PLoS One. 2023;18:e0285683.
    PubMed     Abstract available


  57. YAGHMAEI E, Pierce A, Lu H, Patel YM, et al
    A causal inference study: The impact of the combined administration of Donepezil and Memantine on decreasing hospital and emergency department visits of Alzheimer's disease patients.
    PLoS One. 2023;18:e0291362.
    PubMed     Abstract available


  58. STOLZENBURG LR, Esmaeeli S, Kulkarni AS, Murphy E, et al
    Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model.
    PLoS One. 2023;18:e0291029.
    PubMed     Abstract available


  59. NGUYEN TTT, Lee HH, Huang LK, Hu CJ, et al
    Heterogeneity of Alzheimer's disease identified by neuropsychological test profiling.
    PLoS One. 2023;18:e0292527.
    PubMed     Abstract available


  60. ZHANG GH, Chin KL, Yan SY, Pare R, et al
    Antioxioxidant and antiapoptotic effects of Thymosin beta4 in Abeta-induced SH-SY5Y cells via the 5-HTR1A/ERK axis.
    PLoS One. 2023;18:e0287817.
    PubMed     Abstract available


  61. HENRY DS, Pellegrino RG
    A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
    PLoS One. 2023;18:e0292863.
    PubMed     Abstract available


  62. ZHOU Q, Yang D, Xiong C, Li X, et al
    Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292987.
    PubMed     Abstract available


  63. BOYANOVA ST, Lloyd-Morris E, Corpe C, Rahman KM, et al
    Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
    PLoS One. 2023;18:e0286278.
    PubMed     Abstract available


  64. KOYCHEV I, Marinov E, Young S, Lazarova S, et al
    Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.
    PLoS One. 2023;18:e0288039.
    PubMed     Abstract available


  65. ISMAIL H, Khalid D, Waseem D, Ijaz MU, et al
    Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    PLoS One. 2023;18:e0286349.
    PubMed     Abstract available


  66. BESSER LM, Chrisphonte S, Kleiman MJ, O'Shea D, et al
    The Healthy Brain Initiative (HBI): A prospective cohort study protocol.
    PLoS One. 2023;18:e0293634.
    PubMed     Abstract available


  67. LI F, Chen H, Mao N, Liu H, et al
    Dietary fiber intake and cognitive impairment in older patients with chronic kidney disease in the United States: A cross-sectional study.
    PLoS One. 2023;18:e0291690.
    PubMed     Abstract available


  68. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    PubMed     Abstract available


  69. PURRO SA, Farmer M, Noble E, Sarell CJ, et al
    Two mouse models of Alzheimer's disease accumulate amyloid at different rates and have distinct Abeta oligomer profiles unaltered by ablation of cellular prion protein.
    PLoS One. 2023;18:e0294465.
    PubMed     Abstract available


  70. JAHAN S, Abu Taher K, Kaiser MS, Mahmud M, et al
    Explainable AI-based Alzheimer's prediction and management using multimodal data.
    PLoS One. 2023;18:e0294253.
    PubMed     Abstract available


  71. ZOU T, Zhou X, Wang Q, Zhao Y, et al
    Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    PLoS One. 2023;18:e0295320.
    PubMed     Abstract available


  72. WU X, Cao S, Zou Y, Wu F, et al
    Traditional Chinese Medicine studies for Alzheimer's disease via network pharmacology based on entropy and random walk.
    PLoS One. 2023;18:e0294772.
    PubMed     Abstract available


  73. ZANG L, Liu X, Li Y, Liu J, et al
    The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer's disease: A meta-analysis.
    PLoS One. 2023;18:e0293977.
    PubMed     Abstract available



  74. Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases.
    PLoS One. 2023;18:e0295638.
    PubMed    


  75. TANKSLEY PT, Logan MW, Barnes JC
    History of incarceration and age-related neurodegeneration: Testing models of genetic and environmental risks in a longitudinal panel study of older adults.
    PLoS One. 2023;18:e0288303.
    PubMed     Abstract available


  76. ZHOU Q, Xiong Z, Yang D, Xiong C, et al
    The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295135.
    PubMed     Abstract available


  77. WANG E, Hagberg O, Malmstrom PU
    The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019.
    PLoS One. 2023;18:e0292174.
    PubMed     Abstract available


    January 2022
  78. KIM HJ, Ryou JH, Choi KT, Kim SM, et al
    Deficits in color detection in patients with Alzheimer disease.
    PLoS One. 2022;17:e0262226.
    PubMed     Abstract available


  79. SHABBIR U, Tyagi A, Ham HJ, Oh DH, et al
    Comprehensive profiling of bioactive compounds in germinated black soybeans via UHPLC-ESI-QTOF-MS/MS and their anti-Alzheimer's activity.
    PLoS One. 2022;17:e0263274.
    PubMed     Abstract available


  80. LEACH JM, Edwards LJ, Kana R, Visscher K, et al
    The spike-and-slab elastic net as a classification tool in Alzheimer's disease.
    PLoS One. 2022;17:e0262367.
    PubMed     Abstract available


  81. JUNG NY, Kim HS, Kim ES, Jeon S, et al
    Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
    PLoS One. 2022;17:e0261007.
    PubMed     Abstract available


  82. HUANG YC, Hsu SM, Shie FS, Shiao YJ, et al
    Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Abeta degradation induced by hyperglycemia: A study of mixed glia cultures.
    PLoS One. 2022;17:e0260966.
    PubMed     Abstract available


  83. QUERFURTH H, Marshall J, Parang K, Rioult-Pedotti MS, et al
    A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.
    PLoS One. 2022;17:e0261696.
    PubMed     Abstract available


  84. LEE JI, Lim JS, Hong JH, Kim S, et al
    Selective neurodegeneration of the hippocampus caused by chronic cerebral hypoperfusion: F-18 FDG PET study in rats.
    PLoS One. 2022;17:e0262224.
    PubMed     Abstract available


  85. SADLEIR KR, Popovic J, Khatri A, Vassar R, et al
    Oral nimodipine treatment has no effect on amyloid pathology or neuritic dystrophy in the 5XFAD mouse model of amyloidosis.
    PLoS One. 2022;17:e0263332.
    PubMed     Abstract available


  86. REHMAN S, Ali Ashfaq U, Sufyan M, Shahid I, et al
    The Insight of In Silico and In Vitro evaluation of Beta vulgaris phytochemicals against Alzheimer's disease targeting acetylcholinesterase.
    PLoS One. 2022;17:e0264074.
    PubMed     Abstract available


  87. SUZUKI Y, Suzuki M, Shigenobu K, Shinosaki K, et al
    A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia.
    PLoS One. 2022;17:e0265484.
    PubMed     Abstract available


  88. ZHANG Q, Yang X, Sun Z
    Classification of Alzheimer's disease progression based on sMRI using gray matter volume and lateralization index.
    PLoS One. 2022;17:e0262722.
    PubMed     Abstract available


  89. MARTIZ RM, Patil SM, Ramu R, M K J, et al
    Discovery of novel benzophenone integrated derivatives as anti-Alzheimer's agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach.
    PLoS One. 2022;17:e0265022.
    PubMed     Abstract available


  90. PAYNE M, Manera V, Robert P, Vandersteen C, et al
    Olfactory identification disorders due to Alzheimer's disease: A new test from France to Quebec.
    PLoS One. 2022;17:e0265764.
    PubMed     Abstract available


  91. IOHAN LDCC, Lambert JC, Costa MR
    Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer's disease and progressive supranuclear palsy.
    PLoS One. 2022;17:e0266405.
    PubMed     Abstract available


  92. SARIS IMJ, Aghajani M, Jongs N, Reus LM, et al
    Cross-disorder and disorder-specific deficits in social functioning among schizophrenia and alzheimer's disease patients.
    PLoS One. 2022;17:e0263769.
    PubMed     Abstract available


  93. MOUSA D, Zayed N, Yassine IA
    Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.
    PLoS One. 2022;17:e0264710.
    PubMed     Abstract available


  94. KORTHAUER LE, Giugliano RP, Guo J, Sabatine MS, et al
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.
    PLoS One. 2022;17:e0266615.
    PubMed     Abstract available


  95. YOUSEFZADEH-NOWSHAHR E, Winter G, Bohn P, Kneer K, et al
    Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting.
    PLoS One. 2022;17:e0266906.
    PubMed     Abstract available


  96. UCHIYAMA S, Kamoi F, Tanaka M, Joko I, et al
    What is the subtype of dementia in patients with fragility hip fracture?
    PLoS One. 2022;17:e0265636.
    PubMed     Abstract available


  97. ABD EL-RAHMAN SS, Fayed HM
    Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFkappaBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats.
    PLoS One. 2022;17:e0265961.
    PubMed     Abstract available


  98. SOLIMAN MG, Davies HA, Sharkey J, Levy R, et al
    Development of amyloid beta gold nanorod aggregates as optoacoustic probes.
    PLoS One. 2022;17:e0259608.
    PubMed     Abstract available


  99. BANACK SA, Stark AC, Cox PA
    A possible blood plasma biomarker for early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0267407.
    PubMed     Abstract available


  100. NAITO N, Hirosawa T, Tsubomoto M, Miyagishi Y, et al
    Prominent gamma band activity during visual motion perception in early-stage Alzheimer's disease.
    PLoS One. 2022;17:e0266693.
    PubMed     Abstract available


  101. SOUDY R, Kimura R, Fu W, Patel A, et al
    Extracellular vesicles enriched with amylin receptor are cytoprotective against the Ass toxicity in vitro.
    PLoS One. 2022;17:e0267164.
    PubMed     Abstract available


  102. HERNANDEZ M, Ramon-Julvez U, Ferraz F
    Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer's disease diagnosis.
    PLoS One. 2022;17:e0264695.
    PubMed     Abstract available


  103. PHAM H, Yin T, D'Adamio L
    Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Abeta-coding region of App.
    PLoS One. 2022;17:e0263546.
    PubMed     Abstract available


  104. ANDRADE JM, Pachar P, Trujillo L, Cartuche L, et al
    Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador.
    PLoS One. 2022;17:e0268292.
    PubMed     Abstract available


  105. CANNAVO C, Cleverley K, Maduro C, Mumford P, et al
    Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    PLoS One. 2022;17:e0262558.
    PubMed     Abstract available


  106. ALI M, Sung YJ, Wang F, Fernandez MV, et al
    Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk.
    PLoS One. 2022;17:e0267298.
    PubMed     Abstract available


  107. GARCIA MARIN ID, Camarillo Lopez RH, Martinez OA, Padilla-Martinez II, et al
    New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Abeta aggregation, AChE, and BACE1 in the Alzheimer disease.
    PLoS One. 2022;17:e0269129.
    PubMed     Abstract available


  108. SELF W, Awwad K, Savaryn JP, Schulz M, et al
    An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
    PLoS One. 2022;17:e0269157.
    PubMed     Abstract available


  109. ZAMANI J, Sadr A, Javadi AH
    Classification of early-MCI patients from healthy controls using evolutionary optimization of graph measures of resting-state fMRI, for the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2022;17:e0267608.
    PubMed     Abstract available


  110. LEE H, Kim HK, Kim B, Han K, et al
    Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.
    PLoS One. 2022;17:e0269911.
    PubMed     Abstract available


  111. FLO BK, Matziorinis AM, Skouras S, Sudmann TT, et al
    Study protocol for the Alzheimer and music therapy study: An RCT to compare the efficacy of music therapy and physical activity on brain plasticity, depressive symptoms, and cognitive decline, in a population with and at risk for Alzheimer's disease.
    PLoS One. 2022;17:e0270682.
    PubMed     Abstract available


  112. ALI SK, Ali RH
    Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
    PLoS One. 2022;17:e0271138.
    PubMed     Abstract available


  113. CUADRADO F, Antoli A, Fernandez-Calvo B
    The effect of framing on attitudes towards Alzheimer's disease. A comparative study between younger and older adults.
    PLoS One. 2022;17:e0270959.
    PubMed     Abstract available


  114. KANNAPPAN B, Gunasekaran TI, Te Nijenhuis J, Gopal M, et al
    Polygenic score for Alzheimer's disease identifies differential atrophy in hippocampal subfield volumes.
    PLoS One. 2022;17:e0270795.
    PubMed     Abstract available


  115. VIDONI ED, Morris JK, Palmer JA, Li Y, et al
    Dementia risk and dynamic response to exercise: A non-randomized clinical trial.
    PLoS One. 2022;17:e0265860.
    PubMed     Abstract available


  116. KHASAWNEH RR, Abu-El-Rub E, Alzu'bi A, Abdelhady GT, et al
    Corpus callosum anatomical changes in Alzheimer patients and the effect of acetylcholinesterase inhibitors on corpus callosum morphometry.
    PLoS One. 2022;17:e0269082.
    PubMed     Abstract available


  117. BAJIC VP, Salhi A, Lakota K, Radovanovic A, et al
    DES-Amyloidoses "Amyloidoses through the looking-glass": A knowledgebase developed for exploring and linking information related to human amyloid-related diseases.
    PLoS One. 2022;17:e0271737.
    PubMed     Abstract available


  118. BRAIN J, Tully PJ, Turnbull D, Tang E, et al
    Risk factors for dementia in the context of cardiovascular disease: A protocol of an overview of reviews.
    PLoS One. 2022;17:e0271611.
    PubMed     Abstract available


  119. TEJADA MORENO JA, Villegas Lanau A, Madrigal Zapata L, Baena Pineda AY, et al
    Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.
    PLoS One. 2022;17:e0269955.
    PubMed     Abstract available


  120. SINCLAIR P, Kabbani N
    Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells.
    PLoS One. 2022;17:e0270479.
    PubMed     Abstract available


  121. FAVERO F, Barberis E, Gagliardi M, Espinoza S, et al
    A Metabologenomic approach reveals alterations in the gut microbiota of a mouse model of Alzheimer's disease.
    PLoS One. 2022;17:e0273036.
    PubMed     Abstract available


  122. ACQUARELLI J, van Laarhoven T, Postma GJ, Jansen JJ, et al
    Convolutional neural networks to predict brain tumor grades and Alzheimer's disease with MR spectroscopic imaging data.
    PLoS One. 2022;17:e0268881.
    PubMed     Abstract available


  123. NAMCHAIW P, Bunreangsri P, Eiamcharoen P, Eiamboonsert S, et al
    An in vitro workflow of neuron-laden agarose-laminin hydrogel for studying small molecule-induced amyloidogenic condition.
    PLoS One. 2022;17:e0273458.
    PubMed     Abstract available


  124. FANG Y, Doyle MF, Chen J, Alosco ML, et al
    Association between inflammatory biomarkers and cognitive aging.
    PLoS One. 2022;17:e0274350.
    PubMed     Abstract available


  125. HLYNIALUK C, Kemper L, Leinonen-Wright K, Petersen RC, et al
    Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia.
    PLoS One. 2022;17:e0274784.
    PubMed     Abstract available


  126. WEI Y, Heun-Johnson H, Tysinger B
    Using dynamic microsimulation to project cognitive function in the elderly population.
    PLoS One. 2022;17:e0274417.
    PubMed     Abstract available


  127. HOHBERGER B, Pruss H, Mardin C, Lammer R, et al
    Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
    PLoS One. 2022;17:e0272811.
    PubMed     Abstract available


  128. SUGIOKA J, Suzumura S, Kuno K, Kizuka S, et al
    Relationship between finger movement characteristics and brain voxel-based morphometry.
    PLoS One. 2022;17:e0269351.
    PubMed     Abstract available


  129. WONG J, Steyn JS, Pienaar IS, Elson JL, et al
    Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations.
    PLoS One. 2022;17:e0276169.
    PubMed     Abstract available


  130. SU S, Esparza TJ, Brody DL
    Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
    PLoS One. 2022;17:e0276107.
    PubMed     Abstract available


  131. KANNAPPAN B, Te Nijenhuis J, Choi YY, Lee JJ, et al
    Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer's disease?
    PLoS One. 2022;17:e0275233.
    PubMed     Abstract available


  132. NASIRI M, Moayedfar S, Purmohammad M, Ghasisin L, et al
    Investigating sentence processing and working memory in patients with mild Alzheimer and elderly people.
    PLoS One. 2022;17:e0266552.
    PubMed     Abstract available


  133. ZARETSKY DV, Zaretskaia MV, Molkov YI
    Patients with Alzheimer's disease have an increased removal rate of soluble beta-amyloid-42.
    PLoS One. 2022;17:e0276933.
    PubMed     Abstract available


  134. RANTS'O TA, van Greunen DG, van der Westhuizen CJ, Riley DL, et al
    The in silico and in vitro analysis of donepezil derivatives for Anopheles acetylcholinesterase inhibition.
    PLoS One. 2022;17:e0277363.
    PubMed     Abstract available


  135. TOLEDO JB, Rashid T, Liu H, Launer L, et al
    SPARE-Tau: A flortaucipir machine-learning derived early predictor of cognitive decline.
    PLoS One. 2022;17:e0276392.
    PubMed     Abstract available


  136. KARAMAN BK, Mormino EC, Sabuncu MR
    Machine learning based multi-modal prediction of future decline toward Alzheimer's disease: An empirical study.
    PLoS One. 2022;17:e0277322.
    PubMed     Abstract available


  137. BARTELS SL, Shaaban CE, Brum WS, Welikovitch LA, et al
    Impact of the COVID-19 pandemic on early career dementia researchers: A global online survey.
    PLoS One. 2022;17:e0277470.
    PubMed     Abstract available


  138. CHAN D, Suk HJ, Jackson BL, Milman NP, et al
    Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies.
    PLoS One. 2022;17:e0278412.
    PubMed     Abstract available


  139. JUNG JH, Kim G, Byun MS, Lee JH, et al
    Gut microbiome alterations in preclinical Alzheimer's disease.
    PLoS One. 2022;17:e0278276.
    PubMed     Abstract available


  140. XIA W, Gao Z, Jiang X, Jiang L, et al
    Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/beta-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer.
    PLoS One. 2022;17:e0278774.
    PubMed     Abstract available


  141. MAFI JN, Walling AM, Villaflores C, Vangala S, et al
    A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias.
    PLoS One. 2022;17:e0277409.
    PubMed     Abstract available


  142. OIZUMI H, Sugimura Y, Totsune T, Kawasaki I, et al
    Plasma sphingolipid abnormalities in neurodegenerative diseases.
    PLoS One. 2022;17:e0279315.
    PubMed     Abstract available


  143. MCCARTHY MM, Hardy MJ, Leising SE, LaFollette AM, et al
    An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish.
    PLoS One. 2022;17:e0271707.
    PubMed     Abstract available


  144. CARDOEN B, Wong T, Alan P, Lee S, et al
    SPECHT: Self-tuning Plausibility based object detection Enables quantification of Conflict in Heterogeneous multi-scale microscopy.
    PLoS One. 2022;17:e0276726.
    PubMed     Abstract available


    January 2021
  145. PENNER G, Lecocq S, Chopin A, Vedoya X, et al
    Aptamarker prediction of brain amyloid-beta status in cognitively normal individuals at risk for Alzheimer's disease.
    PLoS One. 2021;16:e0243902.
    PubMed     Abstract available


  146. VIDONI ED, Morris JK, Watts A, Perry M, et al
    Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial.
    PLoS One. 2021;16:e0244893.
    PubMed     Abstract available


  147. MEGHDADI AH, Stevanovic Karic M, McConnell M, Rupp G, et al
    Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
    PLoS One. 2021;16:e0244180.
    PubMed     Abstract available


  148. TOKUMITSU K, Yasui-Furukori N, Takeuchi J, Yachimori K, et al
    The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone.
    PLoS One. 2021;16:e0247427.
    PubMed     Abstract available


  149. CHELLAPPA RC, Lukose B, Rani P
    Correction: G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2021;16:e0248252.
    PubMed     Abstract available


  150. VOIGT RM, Raeisi S, Yang J, Leurgans S, et al
    Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    PLoS One. 2021;16:e0240342.
    PubMed     Abstract available


  151. GJERUM L, Andersen BB, Bruun M, Simonsen AH, et al
    Comparison of the clinical impact of 2-[18F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer's disease.
    PLoS One. 2021;16:e0248413.
    PubMed     Abstract available


  152. ZABEL P, Kaluzny JJ, Zabel K, Kaluzna M, et al
    Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer's disease and glaucoma.
    PLoS One. 2021;16:e0248284.
    PubMed     Abstract available


  153. BAHADO-SINGH RO, Vishweswaraiah S, Aydas B, Yilmaz A, et al
    Artificial intelligence and leukocyte epigenomics: Evaluation and prediction of late-onset Alzheimer's disease.
    PLoS One. 2021;16:e0248375.
    PubMed     Abstract available


  154. KIM D, Lee JH, Kim HY, Shin J, et al
    Correction: Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2021;16:e0250194.
    PubMed     Abstract available


  155. TSUNEISHI M, Yamamoto T, Yamaguchi T, Kodama T, et al
    Association between number of teeth and Alzheimer's disease using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    PLoS One. 2021;16:e0251056.
    PubMed     Abstract available


  156. VELAZQUEZ M, Lee Y
    Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
    PLoS One. 2021;16:e0244773.
    PubMed     Abstract available


  157. MCCORMICK JW, Ammerman L, Chen G, Vogel PD, et al
    Transport of Alzheimer's associated amyloid-beta catalyzed by P-glycoprotein.
    PLoS One. 2021;16:e0250371.
    PubMed     Abstract available


  158. WEN LY, Wan L, Lai JN, Chen CS, et al
    Increased risk of Alzheimer's disease among patients with age-related macular degeneration: A nationwide population-based study.
    PLoS One. 2021;16:e0250440.
    PubMed     Abstract available


  159. STOJANOVIC F, Taktek M, Khieu NH, Huang J, et al
    NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
    PLoS One. 2021;16:e0250568.
    PubMed     Abstract available


  160. ZHENG C, Xu R
    Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization.
    PLoS One. 2021;16:e0250278.
    PubMed     Abstract available


  161. JIANG X, Howard JH Jr, Rebeck GW, Turner RS, et al
    Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease.
    PLoS One. 2021;16:e0252958.
    PubMed     Abstract available


  162. ZHANG J, Zhang Y, Zou J, Cao F, et al
    A meta-analysis of cohort studies: Traumatic brain injury and risk of Alzheimer's Disease.
    PLoS One. 2021;16:e0253206.
    PubMed     Abstract available


  163. FUKUI K, Kimura S, Kato Y, Kohno M, et al
    Effects of far infrared light on Alzheimer's disease-transgenic mice.
    PLoS One. 2021;16:e0253320.
    PubMed     Abstract available


  164. WENG J, Zhao G, Weng L, Guan J, et al
    Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease.
    PLoS One. 2021;16:e0252969.
    PubMed     Abstract available


  165. MINICUCCI J, Alfond M, Demuro A, Gerberry D, et al
    Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte.
    PLoS One. 2021;16:e0246116.
    PubMed     Abstract available


  166. TOPPING M, Kim J, Fletcher J
    Geographic variation in Alzheimer's disease mortality.
    PLoS One. 2021;16:e0254174.
    PubMed     Abstract available


  167. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available


  168. LIBOWITZ MR, Wei K, Tran T, Chu K, et al
    Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.
    PLoS One. 2021;16:e0254332.
    PubMed     Abstract available


  169. HUI J, Zhao Y, Yu S, Liu J, et al
    Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer's disease patients: A meta-analysis.
    PLoS One. 2021;16:e0255362.
    PubMed     Abstract available


  170. LEE SH, Chen YH, Chien CC, Yan YH, et al
    Three month inhalation exposure to low-level PM2.5 induced brain toxicity in an Alzheimer's disease mouse model.
    PLoS One. 2021;16:e0254587.
    PubMed     Abstract available


  171. SAKUTA S, Hashimoto M, Ikeda M, Koyama A, et al
    Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?
    PLoS One. 2021;16:e0247184.
    PubMed     Abstract available


  172. PIERSSON AD, Ibrahim B, Suppiah S, Mohamad M, et al
    Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design.
    PLoS One. 2021;16:e0252883.
    PubMed     Abstract available


  173. WICKLAND DP, Ren Y, Sinnwell JP, Reddy JS, et al
    Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies.
    PLoS One. 2021;16:e0249305.
    PubMed     Abstract available


  174. VESPA A, Spatuzzi R, Fabbietti P, Penna M, et al
    Association between care burden, depression and personality traits in Alzheimer's caregiver: A pilot study.
    PLoS One. 2021;16:e0251813.
    PubMed     Abstract available


  175. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed     Abstract available


  176. KOLINGER GD, Vallez Garcia D, Willemsen ATM, Reesink FE, et al
    Amyloid burden quantification depends on PET and MR image processing methodology.
    PLoS One. 2021;16:e0248122.
    PubMed     Abstract available


  177. FERNANDEZ-BLAZQUEZ MA, Del Ser T, Frades-Payo B, Avila-Villanueva M, et al
    MADRID+90 study on factors associated with longevity: Study design and preliminary data.
    PLoS One. 2021;16:e0251796.
    PubMed     Abstract available


  178. CALDERON C, Beyle C, Veliz-Garcia O, Bekios-Calfa J, et al
    Psychometric properties of Addenbrooke's Cognitive Examination III (ACE-III): An item response theory approach.
    PLoS One. 2021;16:e0251137.
    PubMed     Abstract available


  179. AKBOR MM, Kurosawa N, Nakayama H, Nakatani A, et al
    Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta.
    PLoS One. 2021;16:e0248027.
    PubMed     Abstract available


  180. PARWEEN F, Hossain MS, Singh KP, Gupta RD, et al
    Association between human paraoxonase 2 protein and efficacy of acetylcholinesterase inhibiting drugs used against Alzheimer's disease.
    PLoS One. 2021;16:e0258879.
    PubMed     Abstract available


  181. NOGUCHI-SHINOHARA M, Koike M, Morise H, Kudo K, et al
    MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease.
    PLoS One. 2021;16:e0259677.
    PubMed     Abstract available


  182. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed     Abstract available


  183. WU Y, Whittaker HT, Noy S, Cleverley K, et al
    The effects of Cstb duplication on APP/amyloid-beta pathology and cathepsin B activity in a mouse model.
    PLoS One. 2021;16:e0242236.
    PubMed     Abstract available


  184. JIANG H, Esparza TJ, Kummer TT, Brody DL, et al
    Unbiased high-content screening reveals Abeta- and tau-independent synaptotoxic activities in human brain homogenates from Alzheimer's patients and high-pathology controls.
    PLoS One. 2021;16:e0259335.
    PubMed     Abstract available


  185. JIANG J, Liu H, Wang Z, Tian H, et al
    Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model.
    PLoS One. 2021;16:e0259530.
    PubMed     Abstract available


  186. CZAPSKI GA, Cieslik M, Bialopiotrowicz E, Lukiw WJ, et al
    Down-regulation of cyclin D2 in amyloid beta toxicity, inflammation, and Alzheimer's disease.
    PLoS One. 2021;16:e0259740.
    PubMed     Abstract available


  187. GRUNDMAN J, Spencer B, Sarsoza F, Rissman RA, et al
    Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression.
    PLoS One. 2021;16:e0251611.
    PubMed     Abstract available


  188. WU X, Peng C, Nelson PT, Cheng Q, et al
    Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression.
    PLoS One. 2021;16:e0256648.
    PubMed     Abstract available


  189. SHIMODA A, Li Y, Hayashi H, Kondo N, et al
    Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model.
    PLoS One. 2021;16:e0253988.
    PubMed     Abstract available


  190. XIN XY, Lai ZH, Ding KQ, Zeng LL, et al
    Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.
    PLoS One. 2021;16:e0260498.
    PubMed     Abstract available


  191. HIRALDO-GONZALEZ L, Trillo-Contreras JL, Garcia-Miranda P, Pineda-Sanchez R, et al
    Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
    PLoS One. 2021;16:e0258165.
    PubMed     Abstract available


  192. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
    Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
    PLoS One. 2021;16:e0253216.
    PubMed     Abstract available


  193. SCHOBER J, Polina J, Walters F, Scott N, et al
    NNC 26-9100 increases Abeta1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells.
    PLoS One. 2021;16:e0254242.
    PubMed     Abstract available


  194. KAMAL S, Park I, Kim YJ, Kim YJ, et al
    Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
    PLoS One. 2021;16:e0259051.
    PubMed     Abstract available


  195. ZUELKE AE, Riedel-Heller SG, Wittmann F, Pabst A, et al
    Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline and dementia-protocol for a systematic review and meta-analysis.
    PLoS One. 2021;16:e0256826.
    PubMed     Abstract available


  196. KAYA-TILKI E, Dikmen M
    Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.
    PLoS One. 2021;16:e0260633.
    PubMed     Abstract available


    January 2020
  197. BOUBAKRI A, Leri M, Bucciantini M, Najjaa H, et al
    Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer's disease.
    PLoS One. 2020;15:e0223815.
    PubMed     Abstract available


  198. MITSUMORI R, Sakaguchi K, Shigemizu D, Mori T, et al
    Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer's disease patients.
    PLoS One. 2020;15:e0239196.
    PubMed     Abstract available


  199. RONCERO C, Nikelski J, Probst S, Fernandez A, et al
    The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease.
    PLoS One. 2020;15:e0235810.
    PubMed     Abstract available


  200. GUPTA A, Kennedy K, Perales-Puchalt J, Drew D, et al
    Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.
    PLoS One. 2020;15:e0239871.
    PubMed     Abstract available


  201. GAO Y, Sengupta A, Li M, Zu Z, et al
    Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    PLoS One. 2020;15:e0240513.
    PubMed     Abstract available


  202. C RC, Lukose B, Rani P
    G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    PLoS One. 2020;15:e0225487.
    PubMed     Abstract available


  203. KUEPER JK, Lizotte DJ, Montero-Odasso M, Speechley M, et al
    Cognition and motor function: The gait and cognition pooled index.
    PLoS One. 2020;15:e0238690.
    PubMed     Abstract available


  204. YAO T, Sweeney E, Nagorski J, Shulman JM, et al
    Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    PLoS One. 2020;15:e0241707.
    PubMed     Abstract available


  205. YOKOSAWA K, Kimura K, Takase R, Murakami Y, et al
    Functional decline of the precuneus associated with mild cognitive impairment: Magnetoencephalographic observations.
    PLoS One. 2020;15:e0239577.
    PubMed     Abstract available


  206. AHMED S, Kim BC, Lee KH, Jung HY, et al
    Ensemble of ROI-based convolutional neural network classifiers for staging the Alzheimer disease spectrum from magnetic resonance imaging.
    PLoS One. 2020;15:e0242712.
    PubMed     Abstract available


  207. SEDGHIZADEH MJ, Hojjati H, Ezzatdoost K, Aghajan H, et al
    Olfactory response as a marker for Alzheimer's disease: Evidence from perceptual and frontal lobe oscillation coherence deficit.
    PLoS One. 2020;15:e0243535.
    PubMed     Abstract available


  208. OKUDA M, Fujita Y, Takada-Takatori Y, Sugimoto H, et al
    Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation.
    PLoS One. 2020;15:e0240378.
    PubMed     Abstract available


  209. GUYON A, Rousseau J, Lamothe G, Tremblay JP, et al
    The protective mutation A673T in amyloid precursor protein gene decreases Abeta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
    PLoS One. 2020;15:e0237122.
    PubMed     Abstract available


  210. KIM D, Lee JH, Kim HY, Shin J, et al
    Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model.
    PLoS One. 2020;15:e0243041.
    PubMed     Abstract available


  211. DENG Y, Wu S, Fan H
    Genome-wide pathway-based quantitative multiple phenotypes analysis.
    PLoS One. 2020;15:e0240910.
    PubMed     Abstract available


  212. LI QS, Tian C, Hinds D, Seabrook GR, et al
    The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.
    PLoS One. 2020;15:e0241552.
    PubMed     Abstract available


  213. MENTINK LJ, Thomas J, Melis RJF, Olde Rikkert MGM, et al
    Home-EEG assessment of possible compensatory mechanisms for sleep disruption in highly irregular shift workers - The ANCHOR study.
    PLoS One. 2020;15:e0237622.
    PubMed     Abstract available


  214. GREEN EH, Kikis EA
    Determining the effects of nanoparticulate air pollution on proteostasis in Caenorhabditis elegans.
    PLoS One. 2020;15:e0243419.
    PubMed     Abstract available


  215. BORGSTEDT L, Blobner M, Musiol M, Bratke S, et al
    Neurotoxicity of different amyloid beta subspecies in mice and their interaction with isoflurane anaesthesia.
    PLoS One. 2020;15:e0242989.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.